位置:首页 > 蛋白库 > BACD_BACSU
BACD_BACSU
ID   BACD_BACSU              Reviewed;         472 AA.
AC   P39641;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   03-AUG-2022, entry version 133.
DE   RecName: Full=Alanine--anticapsin ligase {ECO:0000303|PubMed:23317005};
DE            EC=6.3.2.49 {ECO:0000269|PubMed:16030213, ECO:0000269|PubMed:22407814, ECO:0000269|PubMed:23317005, ECO:0000269|PubMed:24702628};
DE   AltName: Full=ATP-dependent dipeptide ligase {ECO:0000303|PubMed:22407814};
DE   AltName: Full=Bacilysin synthetase {ECO:0000303|PubMed:12372825};
DE   AltName: Full=L-Ala-L-amino acid dipeptide ligase {ECO:0000303|PubMed:23317005};
DE   AltName: Full=L-alanine--L-anticapsin ligase {ECO:0000303|PubMed:23317005};
DE   AltName: Full=L-amino acid ligase {ECO:0000303|PubMed:16030213};
DE            Short=Lal {ECO:0000303|PubMed:16030213};
GN   Name=bacD {ECO:0000303|PubMed:15609023};
GN   Synonyms=ywfE {ECO:0000303|PubMed:16030213}; OrderedLocusNames=BSU37710;
GN   ORFNames=ipa-83d;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=7934828; DOI=10.1111/j.1365-2958.1993.tb01963.x;
RA   Glaser P., Kunst F., Arnaud M., Coudart M.P., Gonzales W., Hullo M.-F.,
RA   Ionescu M., Lubochinsky B., Marcelino L., Moszer I., Presecan E.,
RA   Santana M., Schneider E., Schweizer J., Vertes A., Rapoport G., Danchin A.;
RT   "Bacillus subtilis genome project: cloning and sequencing of the 97 kb
RT   region from 325 degrees to 333 degrees.";
RL   Mol. Microbiol. 10:371-384(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   INDUCTION.
RC   STRAIN=168 / 61884;
RX   PubMed=12372825; DOI=10.1074/jbc.m208722200;
RA   Inaoka T., Takahashi K., Ohnishi-Kameyama M., Yoshida M., Ochi K.;
RT   "Guanine nucleotides guanosine 5'-diphosphate 3'-diphosphate and GTP co-
RT   operatively regulate the production of an antibiotic bacilysin in Bacillus
RT   subtilis.";
RL   J. Biol. Chem. 278:2169-2176(2003).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RC   STRAIN=ATCC 15245 / 3349 / IAM 1-3;
RX   PubMed=16030213; DOI=10.1128/jb.187.15.5195-5202.2005;
RA   Tabata K., Ikeda H., Hashimoto S.;
RT   "ywfE in Bacillus subtilis codes for a novel enzyme, L-amino acid ligase.";
RL   J. Bacteriol. 187:5195-5202(2005).
RN   [5]
RP   FUNCTION IN BACILYSIN PRODUCTION, AND GENE NAME.
RX   PubMed=15609023; DOI=10.1007/s00203-004-0743-8;
RA   Steinborn G., Hajirezaei M.-R., Hofemeister J.;
RT   "bac genes for recombinant bacilysin and anticapsin production in Bacillus
RT   host strains.";
RL   Arch. Microbiol. 183:71-79(2005).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=23317005; DOI=10.1021/bi3016229;
RA   Parker J.B., Walsh C.T.;
RT   "Action and timing of BacC and BacD in the late stages of biosynthesis of
RT   the dipeptide antibiotic bacilysin.";
RL   Biochemistry 52:889-901(2013).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOG;
RP   ADP AND MAGNESIUM, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, MUTAGENESIS OF TYR-75 AND SER-184, COFACTOR, REACTION
RP   MECHANISM, AND SUBUNIT.
RX   PubMed=22407814; DOI=10.1002/pro.2058;
RA   Shomura Y., Hinokuchi E., Ikeda H., Senoo A., Takahashi Y., Saito J.,
RA   Komori H., Shibata N., Yonetani Y., Higuchi Y.;
RT   "Structural and enzymatic characterization of BacD, an L-amino acid
RT   dipeptide ligase from Bacillus subtilis.";
RL   Protein Sci. 21:707-716(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 4-468 OF WILD-TYPE AND MUTANT
RP   ALA-332 IN COMPLEX WITH ADP; ALANINE AND PHOSPHATE, FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF GLU-109; GLU-273;
RP   HIS-309; GLU-311; ARG-328 AND TRP-332, COFACTOR, SUBUNIT, AND REACTION
RP   MECHANISM.
RX   PubMed=24702628; DOI=10.1021/bi500292b;
RA   Tsuda T., Asami M., Koguchi Y., Kojima S.;
RT   "Single mutation alters the substrate specificity of L-amino acid ligase.";
RL   Biochemistry 53:2650-2660(2014).
CC   -!- FUNCTION: Part of the bacABCDEFG operon responsible for the
CC       biosynthesis of bacilysin, an irreversible inactivator of the
CC       glutaminase domain of glucosamine synthetase. Catalyzes the formation
CC       of alpha-dipeptides from various L-amino acids in the presence of ATP.
CC       In vivo catalyzes the ligation of L-alanine and L-anticapsin
CC       (epoxycyclohexanonyl-Ala) to produce the final bacilysin antibiotic (L-
CC       Ala-L-4S-cyclohexenonyl-Ala dipeptide). The substrate specificity is
CC       restricted to small amino acids such as L-Ala, for the N-terminal end
CC       of the dipeptide, whereas a wide range of hydrophobic amino acids such
CC       as L-Phe, L-Tyr and L-Met are recognized for the C-terminal end.
CC       {ECO:0000269|PubMed:15609023, ECO:0000269|PubMed:16030213,
CC       ECO:0000269|PubMed:22407814, ECO:0000269|PubMed:23317005,
CC       ECO:0000269|PubMed:24702628}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-alanine + L-anticapsin = ADP + bacilysin + H(+) +
CC         phosphate; Xref=Rhea:RHEA:44332, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57972,
CC         ChEBI:CHEBI:84310, ChEBI:CHEBI:84311, ChEBI:CHEBI:456216;
CC         EC=6.3.2.49; Evidence={ECO:0000269|PubMed:16030213,
CC         ECO:0000269|PubMed:22407814, ECO:0000269|PubMed:23317005,
CC         ECO:0000269|PubMed:24702628};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:22407814, ECO:0000269|PubMed:24702628};
CC       Note=Binds 2 Mg(2+) ions per monomer. {ECO:0000269|PubMed:22407814,
CC       ECO:0000269|PubMed:24702628};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.07 mM for ATP {ECO:0000269|PubMed:16030213};
CC         KM=0.42 mM for L-alanine {ECO:0000269|PubMed:16030213};
CC         KM=1.64 mM for L-alanine {ECO:0000269|PubMed:24702628};
CC         KM=1.7 mM for L-alanine {ECO:0000269|PubMed:22407814};
CC         KM=5.23 mM for L-phenylalanine {ECO:0000269|PubMed:24702628};
CC         KM=20 mM for L-phenylalanine {ECO:0000269|PubMed:22407814};
CC         KM=105.0 mM for L-glutamine {ECO:0000269|PubMed:16030213};
CC         Vmax=0.764 umol/min/mg enzyme for Ala-Gln synthesis
CC         {ECO:0000269|PubMed:16030213};
CC         Note=kcat is 9.32 sec(-1) for ligase activity with alanine as
CC         substrate (PubMed:24702628). kcat is 10.4 sec(-1) for ligase activity
CC         with phenylalanine as substrate (PubMed:24702628). kcat is 630 min(-
CC         1) for ligase activity with alanine and phenylalanine as substrate
CC         (PubMed:22407814). {ECO:0000269|PubMed:22407814,
CC         ECO:0000269|PubMed:24702628};
CC       pH dependence:
CC         Optimum pH is 9.5. {ECO:0000269|PubMed:16030213};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius.
CC         {ECO:0000269|PubMed:16030213};
CC   -!- PATHWAY: Antibiotic biosynthesis; bacilysin biosynthesis.
CC       {ECO:0000305|PubMed:23317005}.
CC   -!- SUBUNIT: Monomer or homodimer. {ECO:0000269|PubMed:22407814,
CC       ECO:0000269|PubMed:24702628}.
CC   -!- INDUCTION: The compound guanosine 5'-diphosphate 3'-diphosphate (ppGpp)
CC       is essential for the transcription of the bacABCDE operon and GTP
CC       regulates the transcription of both this operon and ywfH via the CodY-
CC       mediated regulation system. {ECO:0000269|PubMed:12372825}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X73124; CAA51639.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB15798.1; -; Genomic_DNA.
DR   PIR; S39738; S39738.
DR   RefSeq; NP_391651.1; NC_000964.3.
DR   RefSeq; WP_003242921.1; NZ_JNCM01000034.1.
DR   PDB; 3VMM; X-ray; 2.50 A; A=1-472.
DR   PDB; 3WNZ; X-ray; 1.90 A; A=4-468.
DR   PDB; 3WO0; X-ray; 2.00 A; A=4-468.
DR   PDB; 3WO1; X-ray; 2.30 A; A=4-468.
DR   PDBsum; 3VMM; -.
DR   PDBsum; 3WNZ; -.
DR   PDBsum; 3WO0; -.
DR   PDBsum; 3WO1; -.
DR   AlphaFoldDB; P39641; -.
DR   SMR; P39641; -.
DR   STRING; 224308.BSU37710; -.
DR   PaxDb; P39641; -.
DR   PRIDE; P39641; -.
DR   DNASU; 937214; -.
DR   EnsemblBacteria; CAB15798; CAB15798; BSU_37710.
DR   GeneID; 937214; -.
DR   KEGG; bsu:BSU37710; -.
DR   PATRIC; fig|224308.179.peg.4083; -.
DR   eggNOG; COG0151; Bacteria.
DR   InParanoid; P39641; -.
DR   OMA; FIAPMAK; -.
DR   PhylomeDB; P39641; -.
DR   BioCyc; BSUB:BSU37710-MON; -.
DR   BioCyc; MetaCyc:MON-19123; -.
DR   BRENDA; 6.3.2.49; 658.
DR   SABIO-RK; P39641; -.
DR   UniPathway; UPA00100; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0034026; F:L-amino-acid alpha-ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.1490.20; -; 1.
DR   InterPro; IPR011761; ATP-grasp.
DR   InterPro; IPR013815; ATP_grasp_subdomain_1.
DR   PROSITE; PS50975; ATP_GRASP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic biosynthesis; ATP-binding; Ligase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Reference proteome.
FT   CHAIN           1..472
FT                   /note="Alanine--anticapsin ligase"
FT                   /id="PRO_0000064804"
FT   DOMAIN          142..355
FT                   /note="ATP-grasp"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00409"
FT   BINDING         109
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:22407814"
FT   BINDING         138
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         178
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         182
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:22407814"
FT   BINDING         184..185
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         226..229
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         268
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         273
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   BINDING         309..311
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         311
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         324
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         324
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   BINDING         328..331
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:22407814,
FT                   ECO:0000269|PubMed:24702628"
FT   SITE            332
FT                   /note="Plays a key role in restricting the N-terminal
FT                   substrate specificity to small amino acids such as L-Ala"
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   MUTAGEN         75
FT                   /note="Y->F: Almost no effect on catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:22407814"
FT   MUTAGEN         109
FT                   /note="E->A: Loss of ligase activity."
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   MUTAGEN         184
FT                   /note="S->A: Almost no effect on catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:22407814"
FT   MUTAGEN         273
FT                   /note="E->A: Loss of ligase activity."
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   MUTAGEN         309
FT                   /note="H->R: Loss of ligase activity."
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   MUTAGEN         311
FT                   /note="E->D: Loss of ligase activity."
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   MUTAGEN         328
FT                   /note="R->K: Loss of ligase activity."
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   MUTAGEN         332
FT                   /note="W->A: Hydrolyzes ATP, even in the absence of L-Ala,
FT                   and the structure appears to show a cavity in the N-
FT                   terminal substrate-binding pocket. Also alters the
FT                   substrate specificity and activity depending on the size
FT                   and shape of substituted amino acids."
FT                   /evidence="ECO:0000269|PubMed:24702628"
FT   STRAND          5..9
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          12..15
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           17..27
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          28..35
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           37..39
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           42..51
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          53..57
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           59..61
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           65..68
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           85..99
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          102..107
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           112..122
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           129..134
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           138..147
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          155..158
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           161..171
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          173..181
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   TURN            184..187
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   TURN            194..196
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           197..208
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          220..227
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           233..236
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          238..242
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          244..253
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          256..265
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          275..279
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           284..301
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          305..315
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          319..328
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           334..342
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           346..356
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           357..359
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          364..366
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          371..379
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           381..386
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          395..403
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          414..420
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          426..431
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           433..435
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          439..446
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   HELIX           448..461
FT                   /evidence="ECO:0007829|PDB:3WNZ"
FT   STRAND          463..467
FT                   /evidence="ECO:0007829|PDB:3WNZ"
SQ   SEQUENCE   472 AA;  52267 MW;  0300F4FA6327976A CRC64;
     MERKTVLVIA DLGGCPPHMF YKSAAEKYNL VSFIPRPFAI TASHAALIEK YSVAVIKDKD
     YFKSLADFEH PDSIYWAHED HNKPEEEVVE QIVKVAEMFG ADAITTNNEL FIAPMAKACE
     RLGLRGAGVQ AAENARDKNK MRDAFNKAGV KSIKNKRVTT LEDFRAALEE IGTPLILKPT
     YLASSIGVTL ITDTETAEDE FNRVNDYLKS INVPKAVTFE APFIAEEFLQ GEYGDWYQTE
     GYSDYISIEG IMADGEYFPI AIHDKTPQIG FTETSHITPS ILDEEAKKKI VEAAKKANEG
     LGLQNCATHT EIKLMKNREP GLIESAARFA GWNMIPNIKK VFGLDMAQLL LDVLCFGKDA
     DLPDGLLDQE PYYVADCHLY PQHFKQNGQI PETAEDLVIE AIDIPDGLLK GDTEIVSFSA
     AAPGTSVDLT LFEAFNSIAA FELKGSNSQD VAESIRQIQQ HAKLTAKYVL PV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024